Tectonic Therapeutic (TECX) Change in Accured Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Change in Accured Expenses data on file, last reported at $1.6 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $1.6 million, up 147.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (up 143.08% YoY), and the FY2025 annual result was -$552000.0, up 90.22% from the prior year.
• Change in Accured Expenses improved to $1.6 million in Q1 2026 per TECX's latest filing, from $571000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $2.3 million in Q2 2023 and troughed at -$3.4 million in Q1 2025.
• A 5-year average of -$403294.1 and a median of -$261000.0 in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses soared 979.69% in 2023, then tumbled 347.25% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$2.6 million in 2022, then jumped by 171.13% to $1.8 million in 2023, then sank by 272.49% to -$3.2 million in 2024, then jumped by 117.89% to $571000.0 in 2025, then surged by 185.99% to $1.6 million in 2026.
• Business Quant data shows TECX's Change in Accured Expenses at $1.6 million in Q1 2026, $571000.0 in Q4 2025, and $34000.0 in Q3 2025.